Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092‐22092 STRASS trial
暂无分享,去创建一个
S. Litière | S. Bonvalot | H. Gelderblom | A. Gronchi | R. Haas | N. Andratschke | C. Hurkmans | P. Chung | A. Miah | C. Le Péchoux | E. Clementel | F. Zaffaroni | J. Bovée | B. Kasper | S. Marréaud | D. Weber | J. Stelmes | C. Sangalli | N. Sauvé | R. Bar-Deroma | N. Alyamani | Peter W Chung
[1] Yao Liang,et al. Time to Local Recurrence as a Predictor of Survival in Patients With Soft Tissue Sarcoma of the Extremity and Abdominothoracic Wall , 2020, Frontiers in Oncology.
[2] J. Blay,et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. , 2020, The Lancet. Oncology.
[3] J. Blay,et al. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG , 2020, Cancer.
[4] K. Chouliaras,et al. Recurrence patterns after resection of retroperitoneal sarcomas: An eight‐institution study from the US Sarcoma Collaborative , 2019, Journal of surgical oncology.
[5] J. Blay,et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] S. Bonvalot,et al. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group , 2019, Cancer.
[7] R. Sebro,et al. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas. , 2017, International journal of radiation oncology, biology, physics.
[8] R. Abrams,et al. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. , 2015, International journal of radiation oncology, biology, physics.
[9] Yen-Lin Chen,et al. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. , 2014, International journal of radiation oncology, biology, physics.
[10] Adam P Dicker,et al. Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials. , 2013, Journal of the National Cancer Institute.
[11] Damien C Weber,et al. QA makes a clinical trial stronger: evidence-based medicine in radiation therapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] L. Collette,et al. Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach. , 2012, European journal of cancer.
[13] K. Do,et al. Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy , 2006, Cancer.
[14] Z. Ying,et al. Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .
[15] R. Abrams,et al. Recent developments in radiotherapy , 1992, Current opinion in oncology.
[16] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[17] J. Blay,et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] E. van Limbergen,et al. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. , 2007, International journal of radiation oncology, biology, physics.
[19] S. Steinberg,et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] P. Sugarbaker,et al. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. , 1996, Cancer treatment and research.